Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.1 (
ERK
)
95,504
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
After acclimation to 100, 75 and 50% of Sea Water (SW) external salinities, a significant reduction in
MET
(Mean Epithelial Thickness) and MDR (Mean Diverticular Radius) indicates a decrease in the digestive cell volume dependant on the lowering of environmental salinity. The interstitial connective tissue seems to be unable to osmoregulate and hence stand severe changes in cell size depending on external salinity. 50% SW acclimated periwinkles show a general pattern of general stress response (decreasing
MET
and MDR, and increasing ND -Numerical Density of lysosomes- and lysosomal size). A reduction in number and size of digestive lysosomes in winkles acclimated to 75% of Sea Water evidences the functioning of regulatory mechanism of digestive cell volume.
...
PMID:Responses of winkles digestive cells and their lysosomal system to environmental salinity changes. 205 84
The Raman microprobe technique was applied for analysis of the molecular components at the adhesive interface between 4-META/MMA-TBB resin and dentin. The Raman spectra showed that the 4-META molecules in monomer solution were mostly hydrolyzed into 4-
MET
molecules, which were then co-polymerized with MMA molecules to form resin and resin-reinforced dentin layers. On the basis of line analysis by the Raman microprobe, resin molecules were estimated to penetrate 6 microns into the dentin from the interface. Raman intensity studies indicated that the concentration of 4-
MET
molecular units in the resin-reinforced dentin was more than four times the concentration in the original monomer solution. This demonstrated the excellent infiltration ability of 4-
MET
monomer into dentin substrate in situ.
...
PMID:Vibrational analysis by Raman spectroscopy of the interface between dental adhesive resin and dentin. 206 92
Adhesion of a composite to tooth substrates was studied. The bonding liner was a mixture: camphorquinone, 0.5%; one of four sulfonamides (A, B, C, and D), 0.5%; 4-methacryloxyethyl trimellitate (4-MET), 0, 2, and 5%; in triethyleneglycol dimethacrylate (TEGDMA). The best tensile bond strength to bovine dentin treated with 0.3 M EDTA 2 Na-0.2 M EDTA FeNa (EDTA 3-2) was 7.5 MPa. The bond strength to bovine dentin decreased with the addition of 4-
MET
. The bond strength to bovine enamel treated with 65% phosphoric acid (H3PO4) was 12.0 MPa. The tensile bond strength to bovine enamel treated with EDTA 3-2 was lower than that to enamel treated with 10% citric acid-3% ferric chloride (10-3) and with H3PO4. The polymerization of these liners was characterized by differential scanning calorimetry (DSC). The photocurable bonding liner studied was adequate for clinical studies.
...
PMID:Effect of sulfonamides and 4-MET on adhesion to tooth substrates. 212 55
Effect of adhesion promoting monomers dissolved in photocurable bonding agents on adhesion to ground dentin was investigated. They were MDP, Phosmer-M and 4-
MET
. The effect of those monomers was compared with that of Phenyl-P. The bonding agents contained campherquinone (CQ) as a photosensitizer, N-phenylglycine (NPG) as a reducing agent and TEGDMA as a base monomer. Phenyl-P was the best adhesion promoting monomer among those studied monomers. MDP could not polymerize well enough to give good bond strength. Phosmer-M could permeate through the smeared layer but could not make a stable resin reinforced dentin. 4-
MET
did not permeate through the smeared layer and did not adhere to ground dentin.
...
PMID:[Effect of adhesion promoting monomers on adhesion to ground dentin]. 213 54
There is little information regarding the molecular mechanisms of hepatocarcinogenesis. We studied the p53 gene at the DNA, RNA, and protein level in seven human hepatocellular carcinoma (HCC)-derived cell lines; six of seven showed p53 abnormalities. By Southern blotting, the p53 gene was found to be partially deleted in Hep 3B and rearranged in SK-
HEP
-1 cells. Transcripts of the p53 gene were undetectable in Hep 3B as well as in FOCUS cells that had no apparent deletion or rearrangement of the p53 gene. Immunoprecipitation after [35S]
methionine
labeling of HCC cells demonstrated that p53 protein was absent in Hep 3B and FOCUS and reduced in concentration in PLC/PRF/5 cells. p53 synthesized by Mahlavu cells showed a slower migration on SDS/polyacrylamide gels suggesting it was an abnormal protein. In Huh7 cells, p53 protein had a prolonged half-life leading to its accumulation in the nuclei; increased levels of p53 protein were also found by immunoblotting. The p53 gene and its expression appeared to be unaltered in the hepatoblastoma-derived Hep G2 cell line. We found that the loss of p53 expression did not occur as a late in vitro event in the FOCUS cell line because p53 protein was also nondetectable at an early passage. We conclude that the loss of p53 expression or the presence of abnormal forms of the protein are frequently associated with HCC cell lines. These observations suggest that alterations in p53 may be important events in the transformation of hepatocytes to the malignant phenotype.
...
PMID:Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. 215 27
Plasma met-enkephalin (MET-ENK) levels are increased in type 1 diabetic women and in pregnant diabetic women in comparison with normal women. Plasma
MET
-ENK levels further increase in the peripartum period both in diabetic and non-diabetic females, probably due to the analgesic and behavioural properties of the opioid system.
...
PMID:High levels of circulating met-enkephalin in pregnant and menstruating type 1 diabetic women. 218 95
By using recombinant DNA technology the cytoplasmic and trans-membrane domain of the human interleukin-2 receptor alpha chain (IL-2R alpha, Tac) and of a mutant protein lacking
methionine
-residues 18, 25, 44, 88, 92, 126, 149, 167, 205, and 209 (des-
Met
IL-2R alpha) encoded by a chemically and enzymatically synthesized gene, were deleted. This leads to secretory expression of soluble wild-type and des-
Met
mutant Tac protein of 42-45 kDa after transfection of BHK-21 cells. Transfectants secreted up to 1.6 micrograms soluble wild-type IL-2R alpha protein/10(6) cells in 24 h into the culture medium.
LTK
- cell lines, expressing a large number of wild-type and des-
Met
mutant low-affinity IL-2R alpha of 50-55 kDa on their surface, shed a truncated form of the Tac protein of about 40 kDa into the culture medium. In contrast to wild-type IL-2R alpha, shedding of mutant Tac protein is strongly reduced. This phenomenon might be the result of higher protein stability of the mutant receptor which may also explain the about 10 times higher surface expression of des-
Met
IL-2R alpha in
LTK
- cells. There are no significant differences in the biosynthesis and post-translational modification of mutant or wild-type Tac proteins either in transfected
LTK
- or BHK-21 cells as analysed by pulse/chase labeling experiments.
...
PMID:Analysis of a soluble mutant des-methionine interleukin-2 receptor alpha chain (Tac protein) produced by transfected mammalian cells. 219 Aug 27
This study analyses distribution patterns of the delta F508 mutation of the cystic fibrosis transmembrane conductance regulator gene (CFTR) gene and the cystic fibrosis (CF)-linked marker loci
MET
, D7S23, D7S399, and D7S8 in a sample of 167 (116 complete) CF families from Bohemia and Moravia (Czechoslovakia). DNA typing was performed by polymerase chain reaction amplification, restriction analysis, and agarose or polyacrylamide gel electrophoresis. The frequency of the delta F508 mutation in this sample is 67% and the frequency of the B haplotype is 77.6% on CF chromosomes. Linkage disequilibrium was found between delta F508 and all markers tested.
...
PMID:Frequency of the delta F508 mutation and flanking marker haplotypes at the CF locus from 167 Czech families. 221 Jul 55
Differential polypeptide expression in gene transfer cell lines of limited genetic complexity was analyzed as a gene mapping strategy. Subcellular fractionation preceding two-dimensional gel electrophoretic analysis simplified protein patterns and revealed subcellular location of differentially expressed polypeptides. As a model system, human
MET
oncogene polypeptide was identified in gene transfer lines by this approach. Genes encoding five putative human proteins were identified and provisionally assigned to chromosomal region 7q21-31 or to chromosome 1.
...
PMID:Polyacrylamide gel analysis of polypeptides in gene transfer cell lines. 221 22
We have previously shown that two alleles of the
MET
locus are independently rearranged in the chemically-treated human cell line MNNG-HOS. One allele is the TPR-
MET
oncogene which was activated by fusion of the
MET
locus on chromosome 7 with the TPR locus on chromosome 1. The second allele is found on a der(7)t(1;7)(q23;q32) chromosome and is characterized by a deletion of the amino-terminus of the
MET
extracellular ligand binding domain. Here we present a pulsed field gel electrophoresis analysis which reveals that the two
MET
allele rearrangements in MNNG-HOS cells are more complex than originally thought. The breakpoint in
MET
on der(7) has been molecularly cloned and, unexpectedly, we found that rearrangement in this allele involves sequences derived from chromosome 2. Moreover, the rearrangement producing der(7) involves an inversion of the
MET
locus or a more complex alteration. Analysis of hybrid cells containing TPR-
MET
demonstrated that both the upstream and downstream portions of
MET
are conserved in this rearrangement and that oncogene activation occurred by an insertion of TPR sequences into the
MET
locus. These findings illustrate that when examined at the molecular level some chromosome abnormalities can be extremely complex and, thus, are of limited value in gene mapping studies.
...
PMID:Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS. 225 Sep 12
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>